# EDGAR Filing Document

**Accession Number:** 0001639691
**File Stem:** 0001639691-26-000025
**Filing Date:** 2026-4
**Character Count:** 13053
**Document Hash:** 4cbdfb66bb4d3d4b48a034a53e870bba
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001639691-26-000025.hdr.sgml**: 20260401

**ACCESSION NUMBER**: 0001639691-26-000025

**CONFORMED SUBMISSION TYPE**: 4

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260330

**FILED AS OF DATE**: 20260401

**DATE AS OF CHANGE**: 20260401

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Shvartsburg Alex
- **CENTRAL INDEX KEY:** 0001830830

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 4
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-37599
- **FILM NUMBER:** 26829499

**MAIL ADDRESS:**
- **STREET 1:** 20 EASTBOURNE TERRACE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W26LG
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** LivaNova PLC
- **CENTRAL INDEX KEY:** 0001639691
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 981268150
- **STATE OF INCORPORATION:** X0
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 20 EASTBOURNE TERRACE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W2 6LG
- **BUSINESS PHONE:** 4402033250662

**MAIL ADDRESS:**
- **STREET 1:** 20 EASTBOURNE TERRACE
- **CITY:** LONDON
- **STATE:** X0
- **ZIP:** W2 6LG

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sand Holdco Plc
- **DATE OF NAME CHANGE:** 20150420

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Sand Holdco Ltd
- **DATE OF NAME CHANGE:** 20150415

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 4

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Shvartsburg Alex<br><sub>(Last) (First) (Middle)</sub><br>20 EASTBOURNE TERRACE<br><sub>(Street)</sub><br>LONDON, UNITED KINGDOM W26LG<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-03-30 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Chief Financial Officer_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>LivaNova PLC [ LIVN ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Ordinary Shares | 2026-03-30 |  | M |  | 30835<sup>(1)</sup> | A | $0 | 57515 | D |  |
| Ordinary Shares | 2026-03-30 |  | F |  | 12868<sup>(2)</sup> | D | $61.27 | 44647 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-30 |  | M |  |  | 914 | <sup>(4)</sup> | <sup>(4)</sup> | Ordinary Shares | 914 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-30 |  | M |  |  | 2364 | <sup>(5)</sup> | <sup>(5)</sup> | Ordinary Shares | 2364 | $0 | 2364 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-30 |  | M |  |  | 1787 | <sup>(6)</sup> | <sup>(6)</sup> | Ordinary Shares | 1787 | $0 | 3575 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-30 |  | M |  |  | 3621 | <sup>(7)</sup> | <sup>(7)</sup> | Ordinary Shares | 3621 | $0 | 7240 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | M |  |  | 5768 | <sup>(9)</sup> | <sup>(9)</sup> | Ordinary Shares | 5768 | $0 | 0 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | M |  |  | 5612 | <sup>(10)</sup> | <sup>(10)</sup> | Ordinary Shares | 5612 | $0 | 0 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | M |  |  | 10769 | <sup>(11)</sup> | <sup>(11)</sup> | Ordinary Shares | 10769 | $0 | 0 | D |  |
| Restricted Stock Units | <sup>(3)</sup> | 2026-03-30 |  | A |  | 16321 |  | <sup>(12)</sup> | <sup>(12)</sup> | Ordinary Shares | 16321 | $0 | 16321 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | A |  | 5440 |  | <sup>(13)</sup> | <sup>(13)</sup> | Ordinary Shares | 5440 | $0 | 5440 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | A |  | 5440 |  | <sup>(14)</sup> | <sup>(14)</sup> | Ordinary Shares | 5440 | $0 | 5440 | D |  |
| Performance Stock Units | <sup>(8)</sup> | 2026-03-30 |  | A |  | 5440 |  | <sup>(15)</sup> | <sup>(15)</sup> | Ordinary Shares | 5440 | $0 | 5440 | D |  |

---

### Footnotes:

(1) Reporting person had vested restricted stock units (RSUs) and vested performance stock units (PSUs) settled in ordinary shares of LivaNova PLC (the Company), GBP 1.00 par value.

(2) Shares withheld to satisfy tax liability.

(3) Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

(4) On March 30, 2022, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2023. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2015 Incentive Award Plan (the 2015 Plan) and the award agreement.

(5) On March 30, 2023, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2024. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Company's 2022 Incentive Award Plan (the 2022 Plan) and the award agreement.

(6) On March 30, 2024, reporting person was granted RSUs subject to a four-year vesting in equal annual installments, the first vesting having occurred on March 30, 2025. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the 2022 Plan and the award agreement.

(7) On March 30, 2025, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2026. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the First Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the First A&R 2022 Plan) and the award agreement.

(8) Each PSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the applicable Company incentive award plan identified in the footnote for such grant and the award agreement.

(9) On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's cumulative free cash flow (FCF) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 122.0% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 122.0%, and the actual number of vested shares is presented as the quantity that was acquired.

(10) On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's Return on Investment Capital (ROIC) for performance period 2023-2025 compared to a target determined by the 2022 Plan Administrator. The Company has determined that 118.71% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 118.71%, and the actual number of vested shares is presented as the quantity that was acquired.

(11) On March 30, 2023, reporting person was granted PSUs to vest or lapse on March 30, 2026 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2023 and ending December 31, 2025 relative to the total shareholder return of an index of companies, as determined by the 2022 Plan Administrator. The Company has determined that 113.89% of the underlying PSUs shall vest on March 30, 2026, subject to continued service during the vesting period and the award agreement. The performance achieved was 113.89%, and the actual number of vested shares is presented as the quantity that was acquired.

(12) On March 30, 2026, reporting person was granted RSUs subject to a three-year vesting in equal annual installments, the first vesting occurring on March 30, 2027. The RSUs are subject to forfeiture prior to vesting in accordance with the terms of the Second Amended and Restated LivaNova PLC 2022 Incentive Award Plan (the Second A&R 2022 Plan) and the award agreement.

(13) On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's revenue growth for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

(14) On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on the Company's relative total shareholder return (rTSR) for the three-year period beginning on January 1, 2026 and ending December 31, 2028 relative to the total shareholder return of an index of companies, as determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

(15) On March 30, 2026, reporting person was granted PSUs to vest or lapse on March 30, 2029 based on how the Company's adjusted earnings per share (EPS) for the performance period 2026-2028 compares to a target determined by the Second A&R 2022 Plan Administrator. The number included in column 5 of Table II reflects the target number of PSUs eligible for vesting subject to continued service during the vesting period and the award agreement.

**Signature:** /s/ Sarah K. Mohr, Attorney-in-Fact  
**Date:** 2026-04-01

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**